Soru

Zorluk: Çok zorCardiovascular System

A 62-year-old man with a 40-pack-year smoking history and type 2 diabetes mellitus presents with reproducible, severe cramping pain in his right calf after walking two blocks. The pain reliably resolves with 5 minutes of rest. He has no rest pain, ulceration, or gangrene. Examination reveals diminished pedal pulses on the right. His ankle-brachial index (ABI) is 0.65 in the right leg and 1.05 in the left leg. Assuming his symptoms remain persistently lifestyle-limiting despite strict patient compliance with each preceding intervention, arrange the following management steps in the correct guideline-directed sequential order.

  1. 1Enrollment in a supervised graded treadmill exercise program alongside cardiovascular risk factor modification.
  2. 2Initiation of cilostazol therapy to improve walking distance and provide symptom relief.
  3. 3Anatomic mapping of the lower extremities via computed tomography (CT) or magnetic resonance (MR) angiography.
  4. 4Referral for endovascular stent placement or open surgical bypass grafting.

Cevap

The correct sequential management for intermittent claudication is: 1) Supervised exercise program, 2) Cilostazol therapy, 3) Anatomic mapping (CTA/MRA), and 4) Revascularization.
Guideline-directed management of peripheral arterial disease (PAD) follows a strict stepwise escalation. It begins with conservative therapy (exercise) to promote collateralization. If symptoms persist, adjunctive pharmacotherapy (cilostazol) is added. Only when maximal medical therapy fails to relieve lifestyle-limiting symptoms is procedural intervention considered. At this transition point, anatomic mapping (CTA/MRA) is performed to plan the definitive procedure (endovascular or surgical revascularization).

Adım Adım Çözüm

1
Identify the diagnosis and determine the initial first-line therapy.
The patient has intermittent claudication confirmed by an abnormal ABI. The absolute first step is a supervised graded exercise program and risk factor modification.
Exercise stimulates collateral circulation and is the most effective and safest initial intervention.
2
Determine the next pharmacological step for refractory symptoms.
Initiate cilostazol.
When exercise alone is insufficient to relieve lifestyle-limiting symptoms, cilostazol (a PDE-3 inhibitor) is the guideline-directed adjunctive medical therapy to increase claudication distance.
3
Determine the prerequisite step for procedural intervention.
Perform anatomic mapping with CT or MR angiography.
If symptoms remain refractory despite maximal medical therapy, intervention is warranted. However, advanced imaging must be performed first to precisely map the vascular anatomy and plan the procedural approach.
4
Select the definitive procedural intervention.
Proceed with endovascular or surgical revascularization.
Once the anatomy is mapped and specific occlusive lesions are identified, the patient undergoes the appropriate revascularization procedure to definitively restore arterial flow.

Anahtar Kavram

The management of peripheral arterial disease (PAD) progresses strictly from conservative lifestyle measures (exercise), to pharmacotherapy (cilostazol), to anatomic mapping (CTA/MRA), and finally to revascularization, advancing only when the preceding step fails.
Bu soruyu puanla